Future Health ESG Corp. (FHLT) Files Form 25 to Remove Securities

Rhea-AI Filing Summary

Form 25 filed to remove securities from Nasdaq. Future Health ESG Corp. (FHLT) submitted a Form 25 (Commission File No. 333-258911) to notify removal of its Common Stock, Units, and Warrants from listing on the Nasdaq Stock Market LLC. Issuer address is 8 The Green, Suite #12081, Dover, Delaware 19901; telephone listed as 8,333,888,734.

Regulatory statements and signature. The filing records that Nasdaq complied with 17 CFR 240.12d2-2(b) and that the issuer complied with 17 CFR 240.12d2-2(c) governing voluntary withdrawal. The notice is dated and signed on behalf of Nasdaq by Aravind Menon, Hearings Advisor, on 2025-08-08.

Positive

• Exchange and issuer certify compliance with 17 CFR 240.12d2-2(b) and 17 CFR 240.12d2-2(c).
• Form 25 was executed and dated by Nasdaq (Aravind Menon) on 2025-08-08, indicating procedural completion.

Negative

• Classes to be removed from Nasdaq listing: Common Stock, Units, and Warrants (explicit in the filing).
• Delisting is material and may reduce liquidity and investor access to FHLT securities.

Insights

Financial Analyst

TL;DR: Form 25 signals removal of FHLT securities from Nasdaq, a materially negative event for liquidity and market access.

The filing explicitly notifies Nasdaq that Future Health ESG Corp.'s Common Stock, Units, and Warrants are being removed from listing. Removal from a national exchange is a material corporate event that typically reduces liquidity, may limit investor access to the securities, and can affect valuation and investor confidence. The document does not state reasons for removal beyond the compliance statements; it confirms the procedural filing and signature date of 2025-08-08.

Corporate Governance Expert

TL;DR: The exchange and issuer certify compliance with 17 CFR 240.12d2-2(b) and (c), indicating the delisting notice follows Nasdaq and issuer procedures.

The Form 25 records Nasdaq's certification it complied with 17 CFR 240.12d2-2(b) and states the issuer complied with 17 CFR 240.12d2-2(c) governing voluntary withdrawals. The filing is signed by a Nasdaq official (Aravind Menon) on 2025-08-08, showing procedural completion of the notice. The filing contains no additional governance disclosures, reasons for removal, or mitigation measures.

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

333-258911

Issuer:	Future Health ESG Corp.
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	8 The Green
	Suite #12081
	Dover	DELAWARE	19901
Telephone number:					8,333,888,734

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Common Stock, Unit, Warrant

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2025-08-08	By	Aravind Menon		Hearings Advisor
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Future Health ESG Corp. (FHLT) file with the SEC?

The company is the subject of a Form 25 notification to remove its Common Stock, Units, and Warrants from listing on the Nasdaq Stock Market LLC (Commission File No. 333-258911).

When was the Form 25 signed and by whom?

The Form 25 notification was signed on behalf of Nasdaq by Aravind Menon, Hearings Advisor, on 2025-08-08.

Which classes of securities are affected in the FHLT Form 25?

The filing explicitly lists Common Stock, Units, and Warrants as the classes of securities to be removed from Nasdaq listing.

Does the filing indicate compliance with exchange rules or a voluntary withdrawal?

Yes. The filing states Nasdaq complied with 17 CFR 240.12d2-2(b) and that the issuer complied with 17 CFR 240.12d2-2(c), the provision governing voluntary withdrawal.

What is the issuer's address and telephone as listed in the filing?

The filing lists the issuer address as 8 The Green, Suite #12081, Dover, Delaware 19901 and telephone number 8,333,888,734.